Literature DB >> 26561615

Comparative effects of intraduodenal whey protein hydrolysate on antropyloroduodenal motility, gut hormones, glycemia, appetite, and energy intake in lean and obese men.

Amy T Hutchison1, Christine Feinle-Bisset1, Penelope C E Fitzgerald1, Scott Standfield1, Michael Horowitz1, Peter M Clifton2, Natalie D Luscombe-Marsh3.   

Abstract

BACKGROUND: In lean individuals, intraduodenal protein and lipid modulate gastrointestinal motor and hormone functions and reduce energy intake in a load-dependent manner; protein also stimulates insulin, with modest effects on reducing blood glucose. The effect of intraduodenal lipid on gastrointestinal motor and hormone responses is diminished in obesity; whether the effects of protein are also attenuated remains unclear.
OBJECTIVES: The objectives of this study were to characterize the load-dependent effects of intraduodenal whey protein hydrolysate on antropyloroduodenal pressures, gut hormones, glycemia, appetite, and energy intake in obese subjects and to compare the responses to the higher protein load with those in lean subjects.
DESIGN: We measured antropyloroduodenal pressures, plasma cholecystokinin (CCK), glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), glucagon, insulin, blood glucose, appetite, and energy intake in 12 nondiabetic obese men on 3 separate occasions, in a double-blind, randomized order, during 60-min intraduodenal infusions of hydrolyzed whey protein at either 0 (saline control), 1.5, or 3 kcal/min. Twelve age-matched lean individuals received a 3-kcal/min infusion only. Immediately after the infusions, energy intake from a buffet lunch was quantified.
RESULTS: In obese subjects, protein suppressed antral and duodenal pressures; stimulated plasma CCK, GLP-1, GIP, insulin, and glucagon (all r > 0.57, P < 0.01); and tended to reduce energy intake (r = -10.38, P = 0.057) in a dose-dependent manner. In response to the 3-kcal/min protein load, antropyloroduodenal pressures, CCK, GLP-1, and glucagon did not differ between lean and obese subjects. Insulin release was greater, and GIP release less, in obese than in lean subjects (both P < 0.05), whereas the reduction in glucose was comparable. Energy intake tended to be higher in obese subjects (P = 0.08).
CONCLUSIONS: The gastrointestinal effects of hydrolyzed whey protein remain relatively intact in obesity; however, the observed changes in insulin and GIP suggest early disturbances in the insulin-incretin axis. This study was registered at www.anzctr.org.au as ACTRN 12612000203853.
© 2015 American Society for Nutrition.

Entities:  

Keywords:  blood glucose; cholecystokinin; food intake; gastrointestinal motility; glucagon-like peptide 1; obesity

Mesh:

Substances:

Year:  2015        PMID: 26561615     DOI: 10.3945/ajcn.115.114538

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  13 in total

Review 1.  Gastrointestinal Complications of Obesity.

Authors:  Michael Camilleri; Harmeet Malhi; Andres Acosta
Journal:  Gastroenterology       Date:  2017-02-10       Impact factor: 22.682

2.  Evaluation of casein & whey protein hydrolysates as well as milk fermentates from Lactobacillus helveticus for expression of gut hormones.

Authors:  Dipak Dilip Chaudhari; Rajbir Singh; Rashmi Hogarehalli Mallappa; Namita Rokana; Jai Kumar Kaushik; Rajesh Bajaj; Virender Kumar Batish; Sunita Grover
Journal:  Indian J Med Res       Date:  2017-09       Impact factor: 2.375

Review 3.  Protein Digestion-Derived Peptides and the Peripheral Regulation of Food Intake.

Authors:  Juliette Caron; Dorothée Domenger; Pascal Dhulster; Rozenn Ravallec; Benoit Cudennec
Journal:  Front Endocrinol (Lausanne)       Date:  2017-04-24       Impact factor: 5.555

4.  Co-ingestion of whey protein hydrolysate with milk minerals rich in calcium potently stimulates glucagon-like peptide-1 secretion: an RCT in healthy adults.

Authors:  Yung-Chih Chen; Harry A Smith; Aaron Hengist; Oliver J Chrzanowski-Smith; Ulla Ramer Mikkelsen; Harriet A Carroll; James A Betts; Dylan Thompson; John Saunders; Javier T Gonzalez
Journal:  Eur J Nutr       Date:  2019-09-17       Impact factor: 5.614

Review 5.  Gastrointestinal Sensing of Meal-Related Signals in Humans, and Dysregulations in Eating-Related Disorders.

Authors:  Maryam Hajishafiee; Vida Bitarafan; Christine Feinle-Bisset
Journal:  Nutrients       Date:  2019-06-08       Impact factor: 5.717

6.  Comparative Effects of the Branched-Chain Amino Acids, Leucine, Isoleucine and Valine, on Gastric Emptying, Plasma Glucose, C-Peptide and Glucagon in Healthy Men.

Authors:  Rachel A Elovaris; Vida Bitarafan; Shahram Agah; Sina S Ullrich; Kylie Lange; Michael Horowitz; Christine Feinle-Bisset
Journal:  Nutrients       Date:  2021-05-11       Impact factor: 5.717

Review 7.  Targeted intestinal delivery of incretin secretagogues-towards new diabetes and obesity therapies.

Authors:  Fiona M Gribble; Claire L Meek; Frank Reimann
Journal:  Peptides       Date:  2018-02       Impact factor: 3.750

8.  Effects of Intragastric Administration of Tryptophan on the Blood Glucose Response to a Nutrient Drink and Energy Intake, in Lean and Obese Men.

Authors:  Sina S Ullrich; Penelope C E Fitzgerald; Pieter Giesbertz; Robert E Steinert; Michael Horowitz; Christine Feinle-Bisset
Journal:  Nutrients       Date:  2018-04-08       Impact factor: 5.717

9.  Gastrointestinally Digested Protein from the Insect Alphitobius diaperinus Stimulates a Different Intestinal Secretome than Beef or Almond, Producing a Differential Response in Food Intake in Rats.

Authors:  Alba Miguéns-Gómez; Carme Grau-Bové; Marta Sierra-Cruz; Rosa Jorba-Martín; Aleidis Caro; Esther Rodríguez-Gallego; Raúl Beltrán-Debón; M Teresa Blay; Ximena Terra; Anna Ardévol; Montserrat Pinent
Journal:  Nutrients       Date:  2020-08-07       Impact factor: 5.717

10.  The Postprandial Glycaemic and Hormonal Responses Following the Ingestion of a Novel, Ready-to-Drink Shot Containing a Low Dose of Whey Protein in Centrally Obese and Lean Adult Males: A Randomised Controlled Trial.

Authors:  Kieran Smith; Guy S Taylor; Dean M Allerton; Lise Hoej Brunsgaard; Kelly A Bowden Davies; Emma J Stevenson; Daniel J West
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-18       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.